ESC 365 - Evaluation of the benefit of rivaroxaban on VOYAGER PAD primary composite of limb, heart and brain outcomes using the global rank and win ratio methods

ESC Professional Premium Access

Evaluation of the benefit of rivaroxaban on VOYAGER PAD primary composite of limb, heart and brain outcomes using the global rank and win ratio methods

Session: Peripheral artery disease: tackling the burden and improving outcomes

Topic: Pharmacotherapy

Speaker: Doctor M. Bonaca (Aurora, US)

Event: ESC Congress 2022

Congress Presentation

Add to my library

About the speaker

Doctor Marc Bonaca

University of Colorado Anschutz Medical Campus, Aurora (United States of America)

30 presentations

1 follower

5 more presentations in this session

Nationwide trends and projections of peripheral arterial disease among Danish adults

Speaker: Mrs M. Soegaard (Aalborg, DK)

Evaluation of Takayasu's arteritis activity by ultrasound localization microscopy

Speaker: Doctor G. Goudot (Paris, FR)

Elevated Lipoprotein(a) levels increase Major Adverse Limb Event

Speaker: Doctor A. Guedon (Paris, FR)

Optimal strategy for antiplatelet therapy after endovascular revascularization in patients with lower extremity artery disease

Speaker: Doctor J. Seo (Seoul, KR)

Impact of poor below-the-knee run-off on stent failure of femoro-popliteal arteries in healthy swine model.

Speaker: Doctor N. Nakamura (Isehara, JP)

Access the full session

Peripheral artery disease: tackling the burden and improving outcomes

Speakers: Doctor M. Bonaca, Mrs M. Soegaard, Doctor G. Goudot, Doctor A. Guedon, Doctor J. Seo...

About the event

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources